Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

Related Citations for PubMed (Select 12878918)

1.
2.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
3.

Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods.

COMBINE Study Research Group.

Alcohol Clin Exp Res. 2003 Jul;27(7):1107-22.

PMID:
12878917
4.

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M; COMBINE Study Research Group.

J Stud Alcohol Drugs. 2008 Jan;69(1):5-13.

PMID:
18080059
5.

Relationship between medication adherence and treatment outcomes: the COMBINE study.

Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D.

Alcohol Clin Exp Res. 2008 Sep;32(9):1661-9. doi: 10.1111/j.1530-0277.2008.00743.x. Epub 2008 Jul 9.

6.

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, Couper DJ, Cisler RA; COMBINE Cost-Effectiveness Research Group.

Arch Gen Psychiatry. 2008 Oct;65(10):1214-21. doi: 10.1001/archpsyc.65.10.1214.

7.

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.

Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x. Epub 2010 Jul 20.

8.

Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Doggrell SA.

Expert Opin Pharmacother. 2006 Oct;7(15):2169-73.

PMID:
17020440
9.
10.

Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.

Fucito LM, Park A, Gulliver SB, Mattson ME, Gueorguieva RV, O'Malley SS.

Biol Psychiatry. 2012 Nov 15;72(10):832-8. doi: 10.1016/j.biopsych.2012.03.023. Epub 2012 Apr 26.

11.

Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

Mason BJ.

J Stud Alcohol Suppl. 2005 Jul;(15):148-56; discussion 140. Review.

PMID:
16223066
12.
13.

Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R; COMBINE Study Research Group.

J Stud Alcohol Drugs. 2008 Nov;69(6):878-84.

14.

Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.

Johnson BA, O'Malley SS, Ciraulo DA, Roache JD, Chambers RA, Sarid-Segal O, Couper D.

J Clin Psychopharmacol. 2003 Jun;23(3):281-93.

PMID:
12826990
15.

Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.

Gueorguieva R, Wu R, Krystal JH, Donovan D, O'Malley SS.

Addict Behav. 2013 May;38(5):2119-27. doi: 10.1016/j.addbeh.2013.01.024. Epub 2013 Feb 4.

16.

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.

Balldin J, Berglund M, Borg S, Månsson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson LH, Stolt G, Willander A.

Alcohol Clin Exp Res. 2003 Jul;27(7):1142-9.

PMID:
12878920
17.

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.

Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kämpf P, Stracke R, Baehr M, Naber D, Wiedemann K.

Arch Gen Psychiatry. 2003 Jan;60(1):92-9.

PMID:
12511176
18.

A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.

Laaksonen E, Koski-Jännes A, Salaspuro M, Ahtinen H, Alho H.

Alcohol Alcohol. 2008 Jan-Feb;43(1):53-61. Epub 2007 Oct 27.

19.

Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

Hartzler B, Witkiewitz K, Villarroel N, Donovan D.

Psychol Addict Behav. 2011 Jun;25(2):269-78. doi: 10.1037/a0022869.

20.

Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.

Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A; PREDICT Study Research Team.

Alcohol Clin Exp Res. 2009 Apr;33(4):674-83. doi: 10.1111/j.1530-0277.2008.00884.x. Epub 2009 Jan 20.

PMID:
19170666
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk